Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker XENE
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 9, 2026 | XENE Xenon Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 9, 2026 | XENE Xenon Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 6, 2026 | XENE Xenon Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 6, 2026 | XENE Xenon Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 7, 2026 | XENE Xenon Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 7, 2026 | XENE Xenon Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 13, 2026 | XENE Xenon Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 13, 2026 | XENE Xenon Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 12, 2026 | XENE Xenon Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 12, 2026 | XENE Xenon Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 9, 2026 | XENE Xenon Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 27, 2026 | XENE Xenon Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 26, 2026 | XENE Xenon Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 26, 2026 | XENE Xenon Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 1, 2025 | XENE Xenon Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 3, 2025 | XENE Xenon Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 3, 2025 | XENE Xenon Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 17, 2025 | XENE Xenon Pharmaceuticals Inc. | 8.01 Other Events | 8-K/A | 8-K ↗ |
| Oct 17, 2025 | XENE Xenon Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K/A | 8-K ↗ |
| Oct 16, 2025 | XENE Xenon Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 11, 2025 | XENE Xenon Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 11, 2025 | XENE Xenon Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 3, 2025 | XENE Xenon Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 12, 2025 | XENE Xenon Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 12, 2025 | XENE Xenon Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 17, 2025 | XENE Xenon Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 5, 2025 | XENE Xenon Pharmaceuticals Inc. | 4.01 Changes in Registrant's Certifying Accountant | 8-K | 8-K ↗ |
| Feb 27, 2025 | XENE Xenon Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 27, 2025 | XENE Xenon Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 27, 2025 | XENE Xenon Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 17, 2025 | XENE Xenon Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 12, 2024 | XENE Xenon Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2024 | XENE Xenon Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
36 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:18 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances